@FiercePharma: Healthcare agency, top drugmakers spotlight growing role in public health at UN meeting. FiercePharmaMarketing story | Follow @FiercePharma
@CarlyHFierce: Waiting for flight/playing "guess where these guys work based on overheard description of latest clinical trial failure." | Follow @CarlyHFierce
> The complex--and often secret--nature of drug pricing in the U.S. has complicated public debate about the issue. Report
> Walgreens ($WBA) says it's looking at follow-up specialty pharmacy deals with drugmakers now that it has sealed a pact with troubled Valeant Pharmaceuticals ($VRX) on a slate of meds. Report
> Swedish Orphan Biovitrum said Elocta, a long-acting hemophilia A treatment it developed with Biogen ($BIIB), has been launched in Europe. Release
> SkyePharma said it expects to beat its 2015 forecast thanks to a sales-related milestone payment from its partner on the respiratory med flutiform, Mundipharma. Report
> Valneva said its Japanese encephalitis vaccine won approval in Taiwan through its partner there, Adimmune. Report
Medical Device News
@FierceMedDev: ICYMI: Israeli startup raises $10M to back transcatheter aortic valve stenosis treatment. Article | Follow @FierceMedDev
@EmilyWFierce: Who's on board with Twitter's 10,000 character limit? Pharma brand managers. FiercePharmaMarketing story | Follow @EmilyWFierce
@VarunSaxena2: ICYMI: Startup raises $14M to commercialize its filter to prevent blood clots during hospitalization. Article | Follow @VarunSaxena2
> Illumina focuses on 'holy grail market opportunity' with liquid biopsy spinoff. Article
> Thermo Fisher to buy Affymetrix for $1.3B to beef up in genetic analysis. Report
> JPM: Med tech 'innovation studio' debuts thanks to $15M investment from American Medical Association. Story
Biotech News
@FierceBiotech: The Bradner factor: Roche bags a BET inhibitor in $535M Tensha buyout. Article | Follow @FierceBiotech
@JohnCFierce: Shire finally gets it done, bagging Baxalta in $32B buyout. News | Follow @JohnCFierce
> Accelerator's second NYC biotech startup sets out with $17M and some Gates-backed science. Story
> Sanofi commits €400M to another cancer R&D pact, this time with Innate Pharma. More
> Landmark $1.9B-plus deal for Seres includes PhIII support. Article
Animal Health News
> USDA shifts attention to diagnostics to curb deadly pig virus. More
> China Animal Healthcare creates embarrassment for stakeholder Lilly. Report
> Startup AGL launches dog-collar sensor for remote tracking of chronic illnesses. Story
> Researchers ID link between fish-flavored cat food and thyroid disease. Item
> Zoetis offloads manufacturing sites as CFO embraces activist investors. Article
Biotech IT News
> Roche leads $175M investment in oncology software player Flatiron. News
> MC10 pitches data-gathering wearable patch at research community. Report
> Pfizer taps Adaptive to add NGS, bioinformatics skills to immuno-oncology drive. Story
> Michael J. Fox Foundation signs up for wearable-enabled Phase III trial project. Item
> Vertex inks deal to add Genomics' database, algorithms to drug discovery toolkit. Article
Pharma Marketing News
> Who's on board with Twitter's 10,000 character limit? Pharma brand managers. Story
> Will GSK's no-speaker-fee system work? Execs say yes; critics, not so much. More
> Healthcare agency, top drugmakers spotlight growing role in public health at UN meeting. Article
> Shire to take on hemophilia marketing with long-sought Baxalta buy. Item
And Finally... A large new study, published in the BMJ, found no risk of birth defects from oral contraceptives. Report